Equities

Arcellx Inc

ACLX:NSQ

Arcellx Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)86.95
  • Today's Change-0.270 / -0.31%
  • Shares traded11.38k
  • 1 Year change+62.89%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 14:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Arcellx Inc increased its cash reserves by 498.24%, or 332.22m. Cash Flow from Financing totalled 279.16m or 253.05% of revenues. In addition the company generated 207.57m in cash from operations while cash used for investing totalled 154.51m.
Cash flow per share-0.6947
Price/Cash flow per share--
Book value per share8.95
Tangible book value per share8.95
More ▼

Balance sheet in USDView more

Arcellx Inc has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 394.58m.
Current ratio4.29
Quick ratio--
Total debt/total equity0.0225
Total debt/total capital0.022
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.